| 100852-3 |
Views for metastasis^W Sr-89 IV |
Find |
XXX>Bones |
Pt |
Doc |
NM |
|
ACTIVE |
NM Bones Views for metastasis W Sr-89 IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
100852-3 |
|
NM |
|
|
Both |
|
|
|
0 |
NM Bones Views for mets W Sr-89 IV |
|
|
|
N |
|
Document; Films; Finding; Findings; Imaging; Metastases; Mets; Misc; Miscellaneous; Other; Point in time; Radiology; Random; Spec; To be specified in another part of the message; Unspecified; View; Views for mets; VWS |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100853-1 |
Views for effusion^W radionuclide IV |
Find |
Chest>Pericardial space |
Pt |
Doc |
NM |
|
ACTIVE |
NM Pericardial space Views for effusion |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
100853-1 |
|
NM |
|
|
Both |
|
|
|
0 |
NM Pericard space Views effusion |
|
|
|
N |
|
Document; Films; Finding; Findings; Imaging; Point in time; Radiology; Random; RN; RNC; Scan; Thorax; View; VWS; W RNC IV |
2.81 |
2.73 |
|
|
|
|
|
|
|
|
|
|
Release 2.81: COMPONENT: clarify component of imaging px; LONG_COMMON_NAME: clarify component of imaging px; SHORTNAME: truncated SN; Release 2.79: SYSTEM: Changed RAD imaging focus; |
0 |
| 100854-9 |
Lymphocytes/Cells |
NFr |
Bld MC |
Pt |
Qn |
IA |
|
TRIAL |
Lymphocytes/cells in Blood mononuclear cells by Immunoassay |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MICRO |
|
100854-9 |
|
IA |
|
|
Both |
|
|
|
0 |
Lymphocytes Bld MC IA-NFr |
|
|
|
N |
|
Blood; Cell; Cellularity; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; MEIA; Microbiology; Number Fraction; PBMC; Percent; Peripheral blood mononuclear cells; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS; WB; Whole blood |
2.79 |
2.73 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 100855-6 |
Cells.CD3/Cells |
NFr |
Bld MC |
Pt |
Qn |
|
|
TRIAL |
CD3 cells/cells in Blood mononuclear cells |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MICRO |
|
100855-6 |
|
|
|
|
Both |
|
|
|
0 |
CD3 Cells Bld MC-NFr |
|
|
|
N |
|
Blood; CD3 Cells; Cell; Cellularity; Leu4; Leu-4; Microbiology; Number Fraction; PBMC; Percent; Peripheral blood mononuclear cells; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood |
2.79 |
2.73 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 100856-4 |
Cells.CD3+CD4+/Cells |
NFr |
Bld MC |
Pt |
Qn |
|
|
TRIAL |
CD3+CD4+ (T4 helper) cells/cells in Blood mononuclear cells |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MICRO |
|
100856-4 |
|
|
|
|
Both |
|
|
|
0 |
CD3+CD4+ Cells Bld MC-NFr |
|
|
|
N |
|
Blood; CD3 Cells; CD3+CD4+ Cells; CD3-CD4+; CD4+ T cells; Cell; Cellularity; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Leu4; Leu-4; Microbiology; Number Fraction; PBMC; Percent; Peripheral blood mononuclear cells; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; T4; T-4; T4 helper/inducer cells; W3/25; WB; Whole blood |
2.79 |
2.73 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 100857-2 |
Cells.CD3+CD8+/Cells |
NFr |
Bld MC |
Pt |
Qn |
|
|
TRIAL |
CD3+CD8+ (T8 suppressor) cells/cells in Blood mononuclear cells |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MICRO |
|
100857-2 |
|
|
|
|
Both |
|
|
|
0 |
CD3+CD8+ Cells Bld MC-NFr |
|
|
|
N |
|
Blood; CD3 Cells; CD3+CD8+ Cells; CD8 T cells; Cell; Cellularity; Leu2; Leu-2; Leu4; Leu-4; Microbiology; Number Fraction; PBMC; Percent; Peripheral blood mononuclear cells; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; WB; Whole blood |
2.79 |
2.73 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 100858-0 |
Cells.CD4+CD154+/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide |
NFr |
Bld |
Pt |
Qn |
|
|
TRIAL |
Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MICRO |
|
100858-0 |
|
|
|
|
Both |
|
|
|
0 |
CD4+154/CD4 stim COVID Spike |
|
|
|
N |
|
Blood; CD4 Cells; CD4+154 cells; CD4+154/CD4 stim COVID Spike; CD40 ligand; CD40L; Cell; Cellularity; gp39; Helper T cells; ID; II; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Microbiology; Number Fraction; p Stim COVID Spike; Pept; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T4; T-4; T-BAM; TRAP; Tumor necrosis factor Related Activation Protein; W3/25; WB; Whole blood; X-linked hyper IgM |
2.73 |
2.73 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 100859-8 |
Cells.CD4.Interferon gamma-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide |
NFr |
Bld |
Pt |
Qn |
|
|
TRIAL |
Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MICRO |
|
100859-8 |
|
|
|
|
Both |
|
|
|
0 |
CD4 IFNg/CD4 p Stim COVID Sp |
|
|
|
N |
|
Blood; CD4 Cells; CD4 IFNg cells; CD4 IFNg cells/CD4 cells; CD4 IFNg cells/CD4 cells p Stim COVID Spike; Cell; Cellularity; G-INF; Helper T cells; ID; IFN; IGNF; II; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Microbiology; Number Fraction; p Stim COVID Spike; Pept; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T4; T-4; W3/25; WB; Whole blood |
2.73 |
2.73 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 10086-7 |
ST initial amplitude 6 ms.lead II |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
ST initial amplitude 6 ms in lead II |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10086-7 |
|
EKG |
|
|
Observation |
|
|
|
0 |
ST I-Amp 6ms L-II |
|
|
|
Y |
|
2; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST I-Amp 6ms L-II; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 100860-6 |
Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide |
NFr |
Bld |
Pt |
Qn |
|
|
TRIAL |
Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MICRO |
|
100860-6 |
|
|
|
|
Both |
|
|
|
0 |
CD4 TNFa/CD4 p Stim COVID Sp |
|
|
|
N |
|
Blood; CD4 Cells; CD4 TNFa cells; CD4+TNFa+/CD4; CD4+TNFa+/CD4 stim COVID Spike; Cell; Cellularity; Fac; Fact; Helper T cells; ID; II; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Microbiology; Number Fraction; p Stim COVID Spike; Pept; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T4; T-4; TNF; W3/25; WB; Whole blood |
2.73 |
2.73 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 100861-4 |
Cells.CD4+CD154+/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide |
NFr |
Bld |
Pt |
Qn |
|
|
TRIAL |
Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MICRO |
|
100861-4 |
|
|
|
|
Both |
|
|
|
0 |
CD4+154/CD4 p COVID NuclCap |
|
|
|
N |
|
Blood; CD4 Cells; CD4+154 cells; CD40 ligand; CD40L; Cell; Cellularity; gp39; Helper T cells; ID; II; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Microbiology; Number Fraction; p COVID NuclCap; Pept; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T4; T-4; T-BAM; TRAP; Tumor necrosis factor Related Activation Protein; W3/25; WB; Whole blood; X-linked hyper IgM |
2.73 |
2.73 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 100862-2 |
Cells.CD4.Interferon gamma-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide |
NFr |
Bld |
Pt |
Qn |
|
|
TRIAL |
Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MICRO |
|
100862-2 |
|
|
|
|
Both |
|
|
|
0 |
CD4 IFNg/CD4 p COVID NuclCap |
|
|
|
N |
|
Blood; CD4 Cells; CD4 IFNg cells; CD4 IFNg cells/CD4 cells; Cell; Cellularity; G-INF; Helper T cells; ID; IFN; IGNF; II; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Microbiology; Number Fraction; p COVID NuclCap; Pept; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T4; T-4; W3/25; WB; Whole blood |
2.73 |
2.73 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 100863-0 |
Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide |
NFr |
Bld |
Pt |
Qn |
|
|
TRIAL |
Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MICRO |
|
100863-0 |
|
|
|
|
Both |
|
|
|
0 |
CD4 TNFa/CD4 p COVID NuclCap |
|
|
|
N |
|
Blood; CD4 Cells; CD4 TNFa cells; CD4+TNFa+/CD4; Cell; Cellularity; Fac; Fact; Helper T cells; ID; II; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Microbiology; Number Fraction; p COVID NuclCap; Pept; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T4; T-4; TNF; W3/25; WB; Whole blood |
2.73 |
2.73 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 100864-8 |
Giardia lamblia bg gene |
Geno |
XXX |
Pt |
Nom |
Molgen |
|
ACTIVE |
Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100864-8 |
|
Molgen |
|
|
Both |
|
|
|
0 |
G. lamblia bg gene Spec-Geno |
|
|
|
N |
|
Beaver fever; G duodenalis; G intestinalis; G lamblia; Giardiasis; Lamblia intestinalis; Microbiology; Misc; Miscellaneous; Molecular genetics; Nominal; Other; PCR; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100865-5 |
Avian schistosomes DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100865-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Avian schistosomes DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bird; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fowl; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100866-3 |
Febrile antibody profile |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Febrile antibody profile in Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
100866-3 |
|
|
|
|
Order |
|
|
|
0 |
Febrile antibody profile Ser |
|
|
|
N |
|
Ab; Microbiology; Pan; Panel; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Prof; Random; Serum; SR |
2.73 |
2.73 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 100867-1 |
Campylobacter jejuni+coli+lari+upsaliensis Ag |
PrThr |
Stool |
Pt |
Ord |
IA.rapid |
|
ACTIVE |
Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100867-1 |
|
IA.rapid |
|
|
Both |
|
|
|
0 |
C jej+coli+lari+upsa Ag Stl Ql IA.rapid |
|
|
|
N |
|
Antigen; Antigens; Bowel movement; C jej+coli+lari+upsa; C jej+coli+lari+upsa Ag; C jejuni; Campy; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; IAA; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; SUDS |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100868-9 |
Cryptosporidium sp 18S-LC2 rRNA |
Geno |
XXX |
Pt |
Nom |
Molgen |
|
ACTIVE |
Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100868-9 |
|
Molgen |
|
|
Both |
|
|
|
0 |
Cryptosp 18S -LC2 rRNA Spec-Geno |
|
|
|
N |
|
Crypt; Crypto; Cryptosp 18S-LC2; Cryptosp 18S-LC2 rRNA; Cryptosporidiosis; Microbiology; Misc; Miscellaneous; Molecular genetics; Nominal; Other; PCR; Point in time; Random; ribosomal RNA; Spec; species; spp; To be specified in another part of the message; Unspecified |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100869-7 |
Cryptosporidium gp60 gene |
Type |
XXX |
Pt |
Nom |
Molgen |
|
ACTIVE |
Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100869-7 |
|
Molgen |
|
|
Both |
|
|
|
0 |
Crypto gp60 Spec |
|
|
|
N |
|
Crypt; Crypto; Crypto gp60; Cryptosporidiosis; Microbiology; Misc; Miscellaneous; Molecular genetics; Nominal; Other; PCR; Point in time; Random; Spec; To be specified in another part of the message; Typ; Unspecified |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10087-5 |
ST initial amplitude 6 ms.lead III |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
ST initial amplitude 6 ms in lead III |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10087-5 |
|
EKG |
|
|
Observation |
|
|
|
0 |
ST I-Amp 6ms L-III |
|
|
|
Y |
|
3; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST I-Amp 6ms L-III; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 100870-5 |
Cryptosporidium 18S rRNA |
Geno |
XXX |
Pt |
Nom |
Molgen |
|
ACTIVE |
Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100870-5 |
|
Molgen |
|
|
Both |
|
|
|
0 |
Cryptosp 18S rRNA Spec-Geno |
|
|
|
N |
|
Crypt; Crypto; Cryptosp 18S; Cryptosp 18S rRNA; Cryptosporidiosis; Microbiology; Misc; Miscellaneous; Molecular genetics; Nominal; Other; PCR; Point in time; Random; ribosomal RNA; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100871-3 |
Giardia lamblia gdh gene |
Geno |
XXX |
Pt |
Nom |
Molgen |
|
ACTIVE |
Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100871-3 |
|
Molgen |
|
|
Both |
|
|
|
0 |
G. lamblia gdh gene Spec-Geno |
|
|
|
N |
|
Beaver fever; G duodenalis; G intestinalis; G lamblia; G. lamblia gdh gene; Giardiasis; Lamblia intestinalis; Microbiology; Misc; Miscellaneous; Molecular genetics; Nominal; Other; PCR; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100872-1 |
Bacteria producing polysaccharide from sucrose |
PrThr |
Isolate |
Pt |
Ord |
|
|
ACTIVE |
Bacteria producing polysaccharide from sucrose [Presence] in Isolate |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100872-1 |
|
|
|
|
Both |
|
|
|
0 |
Bact polysach from sucrose Islt Ql |
|
|
|
N |
|
Bact; Bact polysach from sucrose; Islt; Isol; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sucro |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100873-9 |
Giardia lamblia tpi gene |
Geno |
XXX |
Pt |
Nom |
Molgen |
|
ACTIVE |
Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100873-9 |
|
Molgen |
|
|
Both |
|
|
|
0 |
G. lamblia tpi gene Spec-Geno |
|
|
|
N |
|
Beaver fever; G duodenalis; G intestinalis; G lamblia; G. lamblia tpi gene; Giardiasis; Lamblia intestinalis; Microbiology; Misc; Miscellaneous; Molecular genetics; Nominal; Other; PCR; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100874-7 |
Basidiobolus sp |
PrThr |
XXX |
Pt |
Ord |
|
|
ACTIVE |
Basidiobolus sp [Presence] in Specimen |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100874-7 |
|
|
|
|
Both |
|
|
|
0 |
Basidiobolus sp Spec Ql |
|
|
|
N |
|
basidiobolomycosis; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; species; spp; To be specified in another part of the message; Unspecified |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |